CTI has spent a considerable amount of time (45yrs) and resources to find the right mix of capabilities for manufacturing high quality electrochemical biosensors. Techniques like ablation, deposition and fine-line screen printing are an art that we have perfected. Many times we have been able to offer customers an alternative and unique approach that has reduced variability, improved cost and eliminated risk. After all, when these devices get commercialized we understand that people and care givers are making important health choices based on these sensors. In fact, we have had customers boomerang back to us due to our unique capability to achieve superior results with our unique mix of capabilities. Pictured are magnified images of a 12.7µ ablated trace, 2µL dried droplet on an electrode and 10mil spiral trace screen printed.